Analyse de l'application PatienTrials pour le 21 décembre

PatienTrials helps pharma companies and clinicians run global clinical trials virtually, more efficiently in a closed community setting over HIPAA & GDPR compliant collaboration platform. PatienTrials aims to improve patient adherence by empowering participants with information on the progress of treatment at their fingertips in a community setting, that promotes self-care. PatienTrials captures high-quality patient generated data through solutions based on instant messaging, HealthKit, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring clinical trials on to a HIPAA & GDPR compliant instant messaging platform.